ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,046 filers reported holding ASTRAZENECA PLC in Q3 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $307,568 | +67.9% | 4,542 | +77.5% | 0.09% | +61.1% |
| Q2 2023 | $183,157 | -44.6% | 2,559 | -46.2% | 0.05% | -43.2% |
| Q1 2023 | $330,331 | +102487.3% | 4,759 | +0.1% | 0.10% | -8.7% |
| Q4 2022 | $322 | -99.9% | 4,756 | 0.0% | 0.10% | +14.3% |
| Q3 2022 | $261,000 | -16.9% | 4,756 | +0.0% | 0.09% | -9.9% |
| Q2 2022 | $314,000 | -10.0% | 4,754 | -9.5% | 0.10% | +4.1% |
| Q1 2022 | $349,000 | -7.2% | 5,254 | -18.6% | 0.10% | -7.6% |
| Q4 2021 | $376,000 | -4.8% | 6,451 | -1.9% | 0.10% | -12.5% |
| Q3 2021 | $395,000 | +0.3% | 6,577 | 0.0% | 0.12% | 0.0% |
| Q2 2021 | $394,000 | -11.7% | 6,577 | -26.7% | 0.12% | -16.7% |
| Q1 2021 | $446,000 | +16.1% | 8,977 | +16.9% | 0.14% | +7.5% |
| Q4 2020 | $384,000 | -12.1% | 7,677 | -3.8% | 0.13% | -23.9% |
| Q3 2020 | $437,000 | +15.0% | 7,977 | +11.0% | 0.18% | +47.9% |
| Q2 2020 | $380,000 | +2614.3% | 7,186 | +2210.6% | 0.12% | +1883.3% |
| Q1 2020 | $14,000 | -12.5% | 311 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $16,000 | – | 311 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |